SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
Amendment No. 5
Exit Filing
West Pharmaceuticals Services, Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
955306-105
(CUSIP Number)
December 31, 2006
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[X] Rule 13d-1(b)
[ ] Rule 13d-(c)
[ ] Rule 13d-1(d)
CUSIP No. 943315-101
--------------------------------------------------------------------------------
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Wilmington Trust Corporation, 51-0328154
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [X]
(b) [ ]
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware corporation
--------------------------------------------------------------------------------
5. SOLE VOTING POWER:
365,264
NUMBER OF -----------------------------------------------------------------
SHARES 6. SHARED VOTING POWER:
BENEFICIALLY
OWNED BY 0
EACH -----------------------------------------------------------------
REPORTING 7. SOLE DISPOSITIVE POWER:
PERSON
WITH: 0
-----------------------------------------------------------------
8. SHARED DISPOSITIVE POWER:
277,466
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
642,730
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [ ]
N/A
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
1.9%
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON
HC
--------------------------------------------------------------------------------
CUSIP No. 955306-105
--------------------------------------------------------------------------------
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Wilmington Trust Company, solely in its capacity as fiduciary 51-0055023
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [X]
(b) [ ]
--------------------------------------------------------------------------------
3. SEC USE ONLY
------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware banking corporation
--------------------------------------------------------------------------------
5. SOLE VOTING POWER:
365,264
NUMBER OF -----------------------------------------------------------------
SHARES 6. SHARED VOTING POWER:
BENEFICIALLY
OWNED BY 0
EACH -----------------------------------------------------------------
REPORTING 7. SOLE DISPOSITIVE POWER:
PERSON
WITH: 0
-----------------------------------------------------------------
8. SHARED DISPOSITIVE POWER:
267,670
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
632,934
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [ ]
N/A
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
1.9%
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
BK
--------------------------------------------------------------------------------
CUSIP No. 955306-105
--------------------------------------------------------------------------------
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Wilmington Trust FSB, solely in its fiduciary capacity 52-1877389
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [X]
(b) [ ]
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Federal Savings Bank
--------------------------------------------------------------------------------
5. SOLE VOTING POWER:
0
NUMBER OF -----------------------------------------------------------------
SHARES 6. SHARED VOTING POWER:
BENEFICIALLY
OWNED BY 0
EACH -----------------------------------------------------------------
REPORTING 7. SOLE DISPOSITIVE POWER:
PERSON
WITH: 0
-----------------------------------------------------------------
8. SHARED DISPOSITIVE POWER:
9,796
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9,796
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [ ]
N/A
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
0%
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
BK
--------------------------------------------------------------------------------
ITEM 1(A). NAME OF ISSUER:
West Pharmaceuticals Services, Inc.
ITEM 1(B). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
101 Gordon Drive
Lionville, PA 19341
ITEM 2(A). NAME OF PERSON FILING:
Wilmington Trust Corporation, Wilmington Trust Company,
Wilmington Trust FSB
ITEM 2(B). ADDRESS OF PRINCIPAL BUSINESS OFFICE, OR IF NONE, RESIDENCE:
1100 North Market Street
Wilmington, DE 19890
ITEM 2(C). CITIZENSHIP:
Wilmington Trust Corporation is a Delaware corporation;
Wilmington Trust Company is a Delaware banking corporation.
Wilmington Trust FSB is a Federal Savings Bank
ITEM 2(D). TITLE OF CLASS OF SECURITIES:
Common Stock
ITEM 2(E). CUSIP NUMBER: 955306-105
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B), OR 13D-2(B) OR
(C), CHECK WHETHER THE PERSON FILING IS A:
(a) [ ] Broker or dealer registered under Section 15 of the Exchange Act.
(b) [X] Bank as defined in Section 3(a)(6) of the Exchange Act.
Wilmington Trust Company and Wilmington Trust FSB are each Banks and are
each direct, wholly-owned subsidiaries of Wilmington Trust Corporation.
(c) [ ] Insurance company as defined in Section 3(a)(19) of the Exchange Act.
(d) [ ] Investment company registered under Section 8 of the Investment
Company Act.
(e) [ ] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
(f) [ ] An employee benefit plan or endowment fund in accordance with Rule
13d-1(b)(1)(ii)(F);
(g) [X] A parent holding company or control person in accordance with Rule
13d-1(b)(1)(ii)(G);
Wilmington Trust Corporation is a Parent Holding Company.
(h) [ ] A savings association as defined in Section 3(b) of the Federal
Deposit Insurance Act;
(i) [ ] A church plan that is excluded from the definition of an investment
company under Section 3(c)(14) of the Investment Company Act;
(j) [X] Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
Wilmington Trust Corporation, Wilmington Trust Company and Wilmington Trust
FSB are a Group.
ITEM 4. OWNERSHIP.
Provide the following information regarding the aggregate number and percentage
of the class of securities of the issuer identified in Item 1.
(a) Amount beneficially owned:
Wilmington Trust Corporation: 642,730 shares
Wilmington Trust Company: 632,934 shares
Wilmington Trust FSB: 9,796 shares
(b) Percent of class:
Wilmington Trust Corporation: 1.9%
Wilmington Trust Company: 1.9%
Wilmington Trust FSB: 0.0%
(c) Number of shares as to which Wilmington Trust Corporation, Wilmington
Trust Company and Wilmington Trust FSB have:
(i) Sole power to vote or to direct the vote 365,264 shares
(ii) Shared power to vote or to direct the vote shares 0
(iii) Sole power to dispose or to direct the disposition of 0 shares
(iv) Shared power to dispose or to direct the disposition of 277,466
shares
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.
If this statement is being filed to report the fact that as of the date hereof
the reporting person has ceased to be the beneficial owner of more than five
percent of the class of securities, check the following [X]
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.
Not applicable.
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE
SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.
Wilmington Trust Company: BK
Wilmington Trust FSB: BK
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.
Wilmington Trust Corporation: HC
Wilmington Trust Company: BK
Wilmington Trust FSB: BK
ITEM 9. NOTICE OF DISSOLUTION OF GROUP.
Not applicable.
ITEM 10. CERTIFICATIONS.
By signing below I certify that, to the best of my knowledge and belief, the
securities referred to above were acquired and are held in the ordinary course
of business and were not acquired and are not held for the purpose of or with
the effect of changing or influencing the control of the issuer of the
securities and were not acquired and are not held in connection with or as a
participant in any transaction having that purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
February 13, 2007 WILMINGTON TRUST CORPORATION
WILMINGTON TRUST COMPANY
WILMINGTON TRUST FSB
By: /s/ Michael A. DiGregorio
------------------------------------
Michael A. DiGregorio
Senior Vice President
Note. Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 13d-7(b) for other
parties for whom copies are to be sent.
Attention. Intentional misstatements or omissions of fact constitute federal
criminal violations (see 18U.S.C.1001).